Correlates of HIV infection among young adult short-term injection drug users

ObjectivesTo identify risks associated with HIV infection among young adult short-term injection drug users. MethodsCurrent injection drug users, between 18 and 29 years of age, were recruited through street outreach to participate in a cross-sectional survey of HIV prevalence by circumstances of drug injection initiation, HIV-related risk behaviors, and a follow-up to estimate HIV incidence. ResultsAt enrollment, 33 (14.4%) of 229 participants were HIV-seropositive. Significant bivariate associations with HIV at the time injection drug use was initiated included age less than or equal to 18 years, having receptive anal sex with the person who assisted with initiation, and having two or more `trainers' before being able to self-inject. Injecting risks positively associated with HIV included cocaine or speedball (heroin and cocaine together) injection versus heroin or amphetamine injection, injecting five or more times per day, daily crack smoking, backloading, sharing needles at peak drug use, and not using a new needle for every injection. Sexual practices associated with HIV included reporting > 100 lifetime sex partners, a history of sexual assault, being gay or bisexual, and trading sex for money or drugs after starting to inject. In a multivariate model, trading anal sex for money or drugs after initiating injection drug use [odds ratio (OR), 14.2; 95% confidence interval (CI) 3.2–62.3], cocaine/speedball injection (OR, 10.3; 95% CI, 2.2–47.9), daily crack smoking (OR, 4.2; 95% CI, 1.7–10.5), and having two or more trainers (OR, 2.6; 95% CI, 1.1–5.9) were independently associated with HIV. During 12 months of follow-up, four persons seroconverted for HIV (annual incidence: 2.6%; 95% CI, 1.1–5.9%) ConclusionsAmong short-term injectors, both sexual and injecting practices were important predictors of HIV infection, indicating that a proportion of HIV infections among young injection drug users can be attributed to sexual transmission. The incidence rate for HIV infection suggests that immediate steps should be taken to prevent new infections among young injection drug users.

[1]  D. Vlahov,et al.  Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. , 1995, Archives of internal medicine.

[2]  A. Abdul-Quader,et al.  Crack use and multiple AIDS risk behaviors. , 1991, Journal of acquired immune deficiency syndromes.

[3]  A Munoz,et al.  The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods , 1991, NIDA research monograph.

[4]  A. Lazzarin,et al.  Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study. , 1992, American journal of epidemiology.

[5]  M. Chiasson,et al.  Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). , 1991, AIDS.

[6]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[7]  A. Edwards,et al.  HIV in UK Prisons: A Review of Seroprevalence, Transmission and Patterns of Risk , 1995, International journal of STD & AIDS.

[8]  D. Vlahov,et al.  Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. , 1993, American journal of epidemiology.

[9]  N. Breslow,et al.  Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. , 1981 .

[10]  D. Vlahov,et al.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. , 1996, American journal of public health.

[11]  P. Narciso,et al.  Monitoring HIV trends in injecting drug users: an Italian experience , 1990, AIDS.

[12]  R A Coutinho,et al.  Young and recent-onset injecting drug users are at higher risk for HIV. , 1997, Addiction.

[13]  M. Rosenbaum,et al.  Women who use cocaine too much: smoking crack vs. snorting cocaine. , 1992, Journal of psychoactive drugs.

[14]  D. Vlahov,et al.  Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. , 1991, The American journal of drug and alcohol abuse.

[15]  W. El-Sadr,et al.  Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. , 1987, AIDS.

[16]  S. Holmberg,et al.  High-risk sex behavior among young street-recruited crack cocaine smokers in three American cities: an interim report. The Multicenter Crack Cocaine and HIV Infection Study Team. , 1992, Journal of psychoactive drugs.

[17]  R. Chaisson,et al.  Cocaine use and HIV infection in intravenous drug users in San Francisco. , 1989, JAMA.

[18]  D. Vlahov,et al.  New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. , 1991, American journal of epidemiology.

[19]  S. Holmberg,et al.  Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. , 1994, The New England journal of medicine.

[20]  D. Vlahov,et al.  The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. , 1994, American journal of public health.

[21]  R. Coutinho,et al.  The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. , 1992, American journal of epidemiology.

[22]  A. Lazzarin,et al.  Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and northern Italy, 1986-1990. , 1992, Journal of Acquired Immune Deficiency Syndromes.

[23]  R. Brookmeyer,et al.  Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. , 1996, The Journal of infectious diseases.

[24]  D. D. Des Jarlais,et al.  Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[25]  P. Selwyn,et al.  Risk factors for human immunodeficiency virus infection in intravenous drug users. , 1989, The New England journal of medicine.